IN VITRO TESTING IN HUMAN CELL LINES FOR ANTIMICROBIAL ACTIVITY AGAINST SARS-COV-2

NIH RePORTER · NIH · N02 · $971,739 · view on reporter.nih.gov ↗

Abstract

This contract provides in vitro testing of potential anti-viral agents, maintenance of viral stocks and cell lines needed to grow the viruses, and development of related assays.

Key facts

NIH application ID
10409305
Project number
75N93021P00602-0-0-1
Recipient
UNIVERSITY OF PENNSYLVANIA
Principal Investigator
SARA CHERRY
Activity code
N02
Funding institute
NIH
Fiscal year
2021
Award amount
$971,739
Award type
Project period
2021-05-03 → 2022-05-02